The predictive value of procalcitonin for postoperative early pancreatic fistula.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
06 May 2020
Historique:
received: 07 03 2020
accepted: 22 04 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 23 9 2020
Statut: epublish

Résumé

To investigate the early prediction value of procalcitonin (PCT) in pancreatic fistula (POPF) after pancreatoduodenectomy (PD). Retrospective analysis of clinical data of 67 patients undergoing pancreaticoduodenectomy (PD) and 19 patients undergoing distalpancreatectomy (DP) were performed in the Department of Hepatobiliary Surgery, Leshan People's Hospital from January 2017 to December 2018. All patients were divided into POPF group and non-POPF group depending on the presence of pancreatic fistula. And fistulas were classified according to the ISGPF classification scheme. Plasma PCT levels, serum CRP concentration, and WBC counts were assessed preoperatively and on postoperative days (PODs) 1, 3, and 5. Statistical analyses were performed with statistical software. The ROC curve was used to analyze the efficacy of PCT and CRP in POPF prediction after surgery and determine their Cut-off value. There were no statistically significant differences identified in age, gender, BMI, diabetes, abdominal surgery history, preoperative laboratory data, operation time, intraoperative bleeding volume, tumor nature and medical expenses of PD patients between the two groups (P > 0.05). While the incidence of postoperative hyperglycemia, postoperative ICU rate and postoperative hospital stay were statistically significant (P < 0.05). The AUC for PCT diagnosis of pancreatic fistula 1 day after surgery was 0.77 (95% CI: 0.675 ~ 0.860). Compared with CRP [0.53 (95% CI: 0.420 ~ 0.639)] and WBC [0.60 (95% CI: 0.490 ~ 0.705)], the optimal cut-off value (cut-off) was 0.67 μg/L. At this time, the sensitivity and specificity of detecting pancreatic fistula were 73.68 and 76.12%, respectively. The results at 3 days after surgery were similar to those at 5 days after surgery. And DP patients had similar results as PD patients. The PCT is valuable for early prediction of pancreatic fistula after Pancreaticoduodenectomy.

Sections du résumé

BACKGROUND BACKGROUND
To investigate the early prediction value of procalcitonin (PCT) in pancreatic fistula (POPF) after pancreatoduodenectomy (PD).
METHOD METHODS
Retrospective analysis of clinical data of 67 patients undergoing pancreaticoduodenectomy (PD) and 19 patients undergoing distalpancreatectomy (DP) were performed in the Department of Hepatobiliary Surgery, Leshan People's Hospital from January 2017 to December 2018. All patients were divided into POPF group and non-POPF group depending on the presence of pancreatic fistula. And fistulas were classified according to the ISGPF classification scheme. Plasma PCT levels, serum CRP concentration, and WBC counts were assessed preoperatively and on postoperative days (PODs) 1, 3, and 5. Statistical analyses were performed with statistical software. The ROC curve was used to analyze the efficacy of PCT and CRP in POPF prediction after surgery and determine their Cut-off value.
RESULT RESULTS
There were no statistically significant differences identified in age, gender, BMI, diabetes, abdominal surgery history, preoperative laboratory data, operation time, intraoperative bleeding volume, tumor nature and medical expenses of PD patients between the two groups (P > 0.05). While the incidence of postoperative hyperglycemia, postoperative ICU rate and postoperative hospital stay were statistically significant (P < 0.05). The AUC for PCT diagnosis of pancreatic fistula 1 day after surgery was 0.77 (95% CI: 0.675 ~ 0.860). Compared with CRP [0.53 (95% CI: 0.420 ~ 0.639)] and WBC [0.60 (95% CI: 0.490 ~ 0.705)], the optimal cut-off value (cut-off) was 0.67 μg/L. At this time, the sensitivity and specificity of detecting pancreatic fistula were 73.68 and 76.12%, respectively. The results at 3 days after surgery were similar to those at 5 days after surgery. And DP patients had similar results as PD patients.
CONCLUSION CONCLUSIONS
The PCT is valuable for early prediction of pancreatic fistula after Pancreaticoduodenectomy.

Identifiants

pubmed: 32375732
doi: 10.1186/s12893-020-00755-2
pii: 10.1186/s12893-020-00755-2
pmc: PMC7201992
doi:

Substances chimiques

Procalcitonin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

90

Références

J Med Biochem. 2017 Apr 22;36(2):122-126
pubmed: 28680355
Ann Surg. 2015 Aug;262(2):378-83
pubmed: 25563864
Exp Ther Med. 2016 Dec;12(6):3499-3506
pubmed: 28105083
Surgery. 2017 May;161(5):1221-1234
pubmed: 28027816
Surgery. 2007 Nov;142(5):761-8
pubmed: 17981197
CA Cancer J Clin. 2013 Sep;63(5):318-48
pubmed: 23856911
HPB (Oxford). 2011 Jun;13(6):377-84
pubmed: 21609369
World J Gastroenterol. 2016 Sep 14;22(34):7797-805
pubmed: 27678363
Ann Surg. 2015 May;261(5):882-7
pubmed: 24979604
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
J Surg Res. 2016 Dec;206(2):280-285
pubmed: 27884320
Br J Surg. 2018 Jun;105(7):811-819
pubmed: 29664999
Ann Hepatobiliary Pancreat Surg. 2017 Nov;21(4):212-216
pubmed: 29264584
J Am Coll Surg. 2013 Jan;216(1):1-14
pubmed: 23122535
J Gastrointest Surg. 2016 Aug;20(8):1482-92
pubmed: 27206502
BMC Res Notes. 2014 Jul 17;7:458
pubmed: 25034373

Auteurs

Quanyu Zhou (Q)

Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan City, Leshan, Sichuan, 614000, People's Republic of China.

Yuxiao Xia (Y)

Department of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, No 15 TaiPing St, Jiangyang District, Luzhou, 64600, Sichuan, People's Republic of China.

Zehua Lei (Z)

Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan City, Leshan, Sichuan, 614000, People's Republic of China. leitseha@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH